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Abstract
Prion diseases, such as bovine spongiform encephalopathies (BSE), are transmissible
neurodegenerative disorders affecting humans and a wide variety of mammals. Variant
Creutzfeldt-Jakob disease (vCJD), a prion disease in humans, has been linked to exposure
to BSE prions. This classical BSE (cBSE) is now rapidly disappearing as a result of appro-
priate measures to control animal feeding. Besides cBSE, two atypical forms (named H-
and L-type BSE) have recently been described in Europe, Japan, and North America. Here
we describe the first wide-spectrum microarray analysis in whole blood of atypical BSE-
infected cattle. Transcriptome changes in infected animals were analyzed prior to and after
the onset of clinical signs. The microarray analysis revealed gene expression changes in
blood prior to the appearance of the clinical signs and during the progression of the disease.
A set of 32 differentially expressed genes was found to be in common between clinical and
preclinical stages and showed a very similar expression pattern in the two phases. A 22-
gene signature showed an oscillating pattern of expression, being differentially expressed
in the preclinical stage and then going back to control levels in the symptomatic phase. One
gene, SEL1L3, was downregulated during the progression of the disease. Most of the stud-
ies performed up to date utilized various tissues, which are not suitable for a rapid analysis
of infected animals and patients. Our findings suggest the intriguing possibility to take
advantage of whole blood RNA transcriptional profiling for the preclinical identification of
prion infection. Further, this study highlighted several pathways, such as immune response
and metabolism that may play an important role in peripheral prion pathogenesis. Finally,
the gene expression changes identified in the present study may be further investigated as
a fingerprint for monitoring the progression of disease and for developing targeted therapeu-
tic interventions.
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Introduction
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a group of fatal
neurodegenerative disorders, which affect humans and a wide variety of animals. They include
Creutzfeldt–Jakob disease (CJD), Gerstmann–Sträussler–Scheinker syndrome (GSS) and fatal
familial insomnia (FFI) in humans [1], scrapie in goats and sheep [2], chronic wasting disease
(CWD) in cervids [3] and bovine spongiform encephalopathy (BSE) in cattle [4]. The etiologi-
cal agent of TSEs is an abnormally folded isoform (PrPSc) of the cellular prion protein (PrPC),
which accumulates in the nervous and lymphoreticular systems during the progression of the
disease [5]. PrPSc accumulation, neuronal loss, spongiosis and astrogliosis are common hall-
marks of prion diseases [6]. Despite the fact that the pathological features of these diseases are
well characterized, the molecular mechanisms and the signaling pathways underlying TSEs are
largely unknown.
The appearance of BSE in the United Kingdom (UK) in 1986 [7] led to an increased interest
in these diseases, especially because of its epidemic nature in the UK. Foodborne transmission
of BSE prions to humans was observed in the 1990s with the appearance of a new variant form
of CJD (vCJD) [8]. It has been shown experimentally that BSE prions have strain characteristics
identical to those of prion isolates from human cases of vCJD [9]. So far, 229 cases of vCJD
have been reported around the world [10]. In recent years, two atypical forms of BSE have
been identified in several European countries [11], Japan [12, 13], the United States [14] and
Canada [15]. The two atypical BSE strains are denoted as H-type BSE and L-type BSE (also
named bovine amyloidotic spongiform encephalopathy, BASE) [16, 17]. The “H” and “L” iden-
tify the higher and lower electrophoretic mobility of the unglycosylated protease resistant PrPSc
fragment, respectively [18]. So far, both atypical subtypes have been identified only in cattle
that were at least eight years old [19]. In view of that, it has been postulated that, unlike classical
BSE (cBSE), cases of atypical BSE may have risen spontaneously, although transmission
through feed or the environment cannot be ruled out. Indeed, histopathological as well as
immunohistochemical analyses showed that atypical forms of BSE can be experimentally trans-
mitted to mice [20–22] as well as to cattle. Moreover, they differ from cBSE and from each
other in terms of clinical features [23–25] and biochemical properties [26–28]. Interestingly,
some recent studies showed that H- and L-type BSE prions may acquire cBSE–like properties
during propagation in animals expressing homologous bovine prion protein [29] or during
inter-species transmission [17, 30], respectively. These findings support the view that the epi-
demic BSE agent could have originated from atypical cattle prions. While cBSE cases are now
rapidly disappearing as a result of appropriate measures to control animal feeding, more
insight into atypical BSE would be necessary in order to carry out risk assessment and to adopt
appropriate control measures.
Given the infective nature of prions, the identification of specific molecular signatures may
be helpful for the development of preclinical diagnostic tests in order to prevent horizontal
transmission of the disease and potentially to develop targeted therapies in humans. High-
throughput genomic techniques, such as DNAmicroarrays and RNA-seq, are the most fre-
quently used methodologies for the identification of differentially expressed genes [31]. Gene
expression approaches were first applied for studying scrapie [32, 33], while for BSE, and par-
ticularly for atypical BSE, they have appeared only recently in the literature [34–36]. Rodent
models have been widely employed for large-scale studies of prion diseases [37, 38]; however, it
is of the utmost importance to extend these studies to the ruminant species naturally affected
by these diseases. In particular, most analyses in cattle have been performed using central ner-
vous system (CNS) tissues from infected animals. Such studies are certainly of relevance but
are not particularly suitable for diagnostic purposes. Also, the large majority of these genomic
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studies have been focused on the cBSE infection, while very few data are available about the
involvement of peripheral tissues in atypical BSE infected cattle [36]. Peripheral blood is a
readily accessible source of biological information on disease status and it is a suitable tissue for
prospective rapid diagnostic tests in animals and patients. The objective of the present study
was to identify molecular patterns in whole blood of atypical BSE-infected cattle in both clinical
and preclinical stages of the disease. Transcriptional changes were analyzed using microarray
technology and data were validated by Reverse Transcriptase quantitative PCR (RT-qPCR).
Materials and Methods
All procedures involving animals were approved by the Home Office of the UK government
according to the Animal (Scientific Procedures) Act 1986 and in conformity with the institu-
tional guidelines of the Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Ao-
sta, Turin, Italy (IZSPLV), that were in compliance with national (D.L. no. 116, G.U. suppl. 40,
Feb. 18, 1992, Circular No.8, G.U., 14 July 1994) and international regulations (EEC Council
Directive 86/609, OJ L 358, 1 Dec.12, 1987). All the experimental protocols proposed were
reviewed and approved by the IZSPLV Animal Care and Use Committee (IACUC).
Blood Samples
Blood samples from 8 BSE-infected cattle (4 with H-type and 4 with L-type BSE) and 2 non-
infected controls were provided by the Biological Archive Group at the Animal and Plant
Health Agency, United Kingdom. All procedures involving animals were approved by the
Home Office of the UK government according to the Animal (Scientific Procedures) Act 1986.
The calves were born by crossing Aberdeen angus with females imported from Denmark (Dan-
ish Holstein, Danish milking red). The inoculation details have been reported previously [23].
Briefly, experimental cattle were intracerebrally inoculated with 1 ml of a 10% brain homoge-
nate of either L-type or H-type BSE at 10–11 months of age [23]. All infected cattle used in this
study were females. The negative controls were age and sex-matched with the infected group.
For each animal, the blood sampling was performed at 2 different time points after inoculation,
corresponding to the preclinical (6-months post infection) and the clinical (from 22 to 26
months post infection) stage of the disease. In this way we obtained 16 samples, 8 in the pre-
clinical and 8 in the clinical stage. The estimated clinical onset after infection was based on the
presence of changes in behavior, unexpected startle responses, and difficulty in rising [23].
Neurological examination and behavioral observations were conducted routinely until the cull-
ing of the animals. TSE infection was confirmed by post-mortem immunohistochemistry on
brain sections of the animals [23]. Detailed information on the husbandry procedures and the
pathological signs have been described in a previous study published by Konold et al. [23].
Finally, blood samples from 6 sex-matched Aberdeen angus from a different herd were added
to the study and used as additional negative controls to obtain a sample size comparable to the
one of the infected animals (8 samples).
RNA Isolation
500 μL of fresh blood were stabilized in 1.3 mL RNAlater1 Solution and immediately frozen at
-20°C. Samples were sent in dry ice to IZSTO (Turin, Italy), where the RNA was isolated
according to the RiboPure™-Blood Kit manufacturer’s instructions (Ambion1). DNase I treat-
ment (Ambion1) was included in the RNA extraction protocol to reduce DNA contamination.
Purified RNA was eluted in 50 μL elution solution and the final concentration, as well as the
absence of protein, was determined using a Thermo Scientific™ NanoDrop 2000 spectropho-
tometer. Since the RNA concentration was too low to proceed with the subsequent analysis,
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the RNA samples were concentrated using a Labconco CentriVap concentrator. The new con-
centration was assessed using a Thermo Scientific™ NanoDrop 2000 spectrophotometer and
the integrity of the RNA was determined by capillary electrophoresis (Agilent 2100 Bioanaly-
zer, Agilent Technologies, Santa Clara, USA).
Microarray Hybridization, Statistical Analysis and Data Mining
24 RNA samples were used for the microarray analysis: 8 preclinical (P1, P2, P4, P5, P7, P8,
EP9 and P10), 8 clinical (S1, S2, S3, S4, S7, S8, S9 and S10), and 8 control (c.2, c.3, c.P3, c.5, c.
S5, C.P6, C.S6 and c.9) samples. 120 ng of each total RNA were used as template for the synthe-
sis of biotin-labeled cRNA according to the standard one-cycle amplification and labeling pro-
tocol developed by Affymetrix (Santa Clara, CA). cRNA was then fragmented and hybridized
on GeneChip1 Bovine Genome Array, which contains over 24128 probe sets. The microarrays
were washed, stained (Affymetrix fluidic station 450 DX) and scanned (Affymetrix scanner
3000 7G). Cell intensity values from the raw array data were computed using the Affymetrix
GeneChip1Operating Software (GCOS). Microarray quality control and statistical analysis
were performed in the software system R using the Bioconductor package OneChannelGUI
[39–41]. The LIMMA algorithm was used to compute a linear model fit [42]. Data filtering and
normalization was carried out using GC-Robust multi-array analysis (GCRMA) from imported
Affymetrix data (.CEL) files. After the assessment and inspection of microarray quality controls
(RNA degradation plot, RLE and NUSE plots) we identified one low quality control sample
(cS5) and excluded it from the analysis (S1 Appendix). Gene probes with a p value0.05 and
fold-change2 were considered to be differentially expressed. Differentially expressed probe
sets were functionally classified using David Bioinformatics tool [43, 44] on the Affymetrix
bovine background. Heat maps were generated using the heatmap.2 function from the gplots
library in the R statistical environment [45, 46]. Probe set data were hierarchically clustered
with complete linkage using the Euclidean metric.
RT-qPCR
To confirm the microarray results, we performed RT-qPCR using SYBR1 green assay (Bio-
Rad Laboratories, Inc.) for a selected number of target genes. The RT-qPCR analysis was per-
formed on 22 samples (from 7 control, 8 preclinical and 7 clinical animals). For each sample,
250 ng of total RNA were used as template for the cDNA synthesis with the SuperScript1 III
Reverse Transcriptase and the Oligo (dT)20 Primer (Life Technologies). PCR primers were
designed using the online tool Primer-BLAST [47] provided by NCBI. Whenever possible, the
primer pairs were designed in order to span an exon-exon junction, thus preventing the ampli-
fication of genomic DNA. The primer sequences were as follows: for GNLY 5’-AGC CCG ATG
AGA ATA CCG TT and 5’- CGA TGT CCT CAG CGA TGG TA; for CD40L 5’-ACA ACC TCT
GTT CTC CAG TG and 5’-GCT GTT TCC CGT TTT CGA GG; for PDK4 5’-TGG TGT TCC
CCT GAG AGT CA and 5’-GTA ACC AAA ACC AGC CAG CG; for HBA2 5’- ACA AGG GCA
ATG TCA AGG CC and 5’- TCG AAG TGG GGG AAG TAG GT; for XIST 5’-GTG GCA AGG
ACC AGA ATG GA and 5’-TCC GAC CCC AGT ATT AGC CA; for GNB4 5’-AGA TCG TGC
AGG TGT TCT TG and 5’-CTG TCC CAA GAC CCT GTT G; for IDO1 5’-ATT GGT GGA GTC
CCT GCA GAC and 5’-CTG CAG GGT AGC ATT GCC TT; for BOLA 5’CTC GTA GTA GCT
GTG GTG GC and 5’ACT GTC ACT GCT TGC AGC C; for SEL1L3 5’-TGA AGG AGT
GGTTTC GCC TG and 5’ TTC AAA TCC TGC CCA GTG CT; for RPL12 5’-AGG GTC TGA
GGA TTA CAG TGA AA and 5’-GAT CAG GGC AGA AGC AGA AGG; for ACTB 5’-GGA CTT
CGA GCA GGA GAT GG and 5’-TTC CAT GCC CAG GAA GGA AG; for GAPDH 5’-AGG TCG
GAG TGA ACG GAT TC and 5’-ATG GCG ACG ATG TCC ACT TT. The RT-qPCR reactions
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were carried out by denaturing at 95°C for 15s, annealing at 60°C for 1 min and extension at
55°C for 1 min for 45 cycles. Melt curve analysis and gel electrophoresis of amplification prod-
ucts were performed for each primer pair to confirm the production of a single PCR amplicon.
The amplification was performed using a CFX96™ Real-Time PCR Detection System (Bio-Rad
Laboratories, Inc.). All the RT-qPCR reactions were run in triplicate and included the following
controls: no template (NTC) and minus-reverse transcriptase (RT-) negative controls. The nor-
malization accuracy was improved by geometric averaging of multiple reference genes [48] and
using two inter-run calibrators to reduce inter-run variation. We decided to use a normaliza-
tion factor based on three reference genes (GAPDH, RPL12 and ACTB) since it has been shown
in the literature that this is the minimal number required for a reliable normalization [49]. Sta-
bility of the selected reference genes was determined by calculating their geNormM value (M)
and the coefficient of variation (CV) on the normalized relative quantities [50]. M and CV val-
ues were then compared against empirically determined thresholds for acceptable stability (~ 1
and ~ 0.5 for M and CV values respectively) [50] (S2 Appendix). The statistical analysis and
the fold change calculation were carried out using qBasePlus 1.1 software [50].
Results
Identification of Differentially Expressed Genes (DEGs) in the Blood of
Atypical BSE-Infected Cattle
To investigate if gene expression alterations were present in blood from atypical BSE-infected
cattle (clinical and preclinical), we performed microarray experiments using Affymetrix Gene-
Chip1 Bovine Genome Array. Since the goal of this project was to identify a common pattern
of DEGs in atypical BSE infection, we defined the 4 H- and the 4 L- type inoculated-cattle as
one single group of 8 animals named as atypical infected cattle. This approach allowed us to
increase the sample size to improve the statistics and thus obtain more reliable results. The dis-
tribution of signal intensities, relative log expression (RLE) and normalized unscaled standard
error (NUSE) plots were examined in order to avoid procedural failures and the presence of
degraded RNA samples. After the assessment of microarray quality controls we identified one
control sample (cS5) as an outlier and excluded it from the analysis (see S1 Appendix). Statisti-
cal analysis was performed on microarray results using the oneChannelGUI Bioconductor
package [39]. The raw microarray data were deposited in the Gene Expression Omnibus
(GEO) repository and assigned the accession number GSE69048. The data sets supporting the
results of this article are available in the Gene Expression Omnibus (GEO) repository: http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=mzgxuaagddwftcz&acc=GSE69048.
Statistical comparison between the infected animals (clinical and preclinical) and the con-
trol group (IvsCtrl) revealed a total of 101 differentially regulated probe sets (p value lower
than 0.05 and changes in expression higher than 2-fold) as shown in Table 1. Some of these
probe sets encoded for the same gene. Gene annotation, performed using DAVID Bioinformat-
ics Resources [43, 44], identified a subset of 93 genes with known functions. The most relevant
functional groups are reported in Table 2.
To evaluate to what extent gene expression alterations in blood were related to the preclini-
cal or clinical stage of the disease, two distinct statistical analyses were performed comparing
each group (8 samples) with the control one: clinical versus control (CvsCtrl) and preclinical
versus control (PvsCtrl). In the clinical stage, a total of 207 probe sets showed significant alter-
ation in expression levels compared to the control group. Among these, 87 were up-regulated
while 120 had a reduction in expression. Interestingly, a pronounced alteration in the gene
expression profile was also found in the preclinical stage, with a total number of 113 differen-
tially expressed probe sets (55 genes were up-regulated while 58 were down-regulated). Two
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Table 1. Differentially expressed genes found in infected animals versus control group by the microarray analysisa.
Probe ID Gene symbol Gene name P value FC
Bt.6653.2.
A1_at
ALKBH4 alkB, alkylation repair homolog 4 (E. coli) 1.35E-07 -2.31687
Bt.8586.1.
S1_at
LOC512150 myeloid-associated differentiation marker-like 4.17E-05 4.192159
Bt.21996.1.
S1_at
IGHE Immunoglobulin heavy constant epsilon 4.77E-05 -5.1041
Bt.16101.1.
S1_s_at
GNLY /// LOC100300483 granulysin /// antimicrobial peptide NK-lysin-like 5.7E-05 -4.17735
Bt.28383.1.
S1_at
GNLY granulysin 8.98E-05 -4.83354
Bt.9265.2.
S1_at
BATF basic leucine zipper transcription factor, ATF-like 0.000112 -2.57096
Bt.14153.1.
S1_at
NEB nebulin 0.000145 -4.89569
Bt.16101.1.
S1_at
GNLY granulysin 0.000212 -4.81011
Bt.12986.1.
S1_at
MAD2L1 MAD2 mitotic arrest deﬁcient-like 1 (yeast) 0.000235 -2.72219
Bt.9265.1.
A1_at
BATF basic leucine zipper transcription factor, ATF-like 0.000236 -2.55269
Bt.23123.1.
S1_at
BHLHE40 basic helix-loop-helix family, member e40 0.000575 -2.36861
Bt.26326.1.
A1_at
MTBP Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)
binding protein, 104kDa
0.000623 2.784763
Bt.22526.1.
S1_at
HSPB8 heat shock 22kDa protein 8 0.000858 -2.39332
Bt.16916.3.
S1_at
KLF11 Kruppel-like factor 11 0.000929 4.455542
Bt.24923.2.
S1_a_at
SEL1L3 sel-1 suppressor of lin-12-like 3 (C. elegans) 0.001057 -3.34168
Bt.8804.1.
S1_at
NELL2 NEL-like 2 (chicken) 0.00117 -2.34981
Bt.28654.1.
S1_at
LOC100850906 /// USP42 ubiquitin carboxyl-terminal hydrolase 42-like /// ubiquitin speciﬁc peptidase 42 0.00132 3.549622
Bt.18321.1.
A1_at
GNB4 guanine nucleotide binding protein (G protein), beta polypeptide 4 0.001338 8.267761
Bt.24630.2.
S1_at
41527 septin 10 0.001368 -3.33002
Bt.21975.1.
S1_at
PRF1 perforin 1 (pore forming protein) 0.001549 -2.00589
Bt.20330.1.
S1_at
PRSS23 protease, serine, 23 0.001702 -3.42322
Bt.24929.1.
A1_at
RG9MTD3 RNA (guanine-9-) methyltransferase domain containing 3 0.001896 2.420786
Bt.6968.1.
S1_at
IPCEF1 Interaction protein for cytohesin exchange factors 1 0.001963 2.424841
Bt.9675.1.
S1_at
LOC100847724 extracellular peptidase inhibitor-like 0.002117 -3.52792
Bt.21979.1.
S1_at
CXCR6 chemokine (C-X-C motif) receptor 6 0.002164 -2.20884
Bt.9504.1.
A1_at
CCL4 chemokine (C-C motif) ligand 4 0.002853 -2.65024
(Continued)
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Table 1. (Continued)
Probe ID Gene symbol Gene name P value FC
Bt.28040.1.
S1_at
LOC781494 myeloid-associated differentiation marker-like 0.002999 -3.59576
Bt.23505.1.
S1_at
PDK4 pyruvate dehydrogenase kinase, isozyme 4 0.003176 3.186119
Bt.24236.1.
S1_at
DLC1 deleted in liver cancer 1 0.003559 2.297004
Bt.26636.1.
S1_at
NKG7 natural killer cell group 7 sequence 0.003806 -2.16912
Bt.6147.1.
S1_a_at
METTL12 methyltransferase like 12 0.00446 -2.15129
Bt.49.1.S1_at CD40LG CD40 ligand 0.004517 -3.23666
Bt.26259.1.
A1_at
ZNF462 zinc ﬁnger protein 462 0.004806 3.969328
Bt.15915.1.
S1_at
LRRC70 leucine rich repeat containing 70 0.005099 2.154164
Bt.17280.1.
S1_at
PLEKHH1 pleckstrin homology domain-containing family H member 1-like 0.005117 2.356958
Bt.29009.1.
A1_at
RYR3 ryanodine receptor 3 0.00525 -5.46377
Bt.2129.1.
S1_at
LOC100850064 versican core protein-like 0.005936 2.001974
Bt.22415.2.
A1_at
LOC512863 sialic acid-binding Ig-like lectin 14-like 0.006306 2.230891
Bt.19308.1.
S1_at
BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 0.006597 3.175266
Bt.16861.1.
A1_at
LOC515128 major facilitator superfamily domain-containing protein 4-like 0.006682 2.319431
Bt.22301.1.
S1_at
ATP6V0A4 ATPase, H+ transporting, lysosomal V0 subunit a4 0.006816 -2.30662
Bt.15705.1.
S1_at
DSTN destrin (actin depolymerizing factor) 0.006907 2.216088
Bt.28637.1.
S1_at
LOC100848843 myeloid-associated differentiation marker-like 0.007707 2.740488
Bt.24983.1.
A1_at
DYNC2H1 dynein, cytoplasmic 2, heavy chain 1 0.008144 -2.08508
Bt.24543.1.
A1_at
KCTD1 potassium channel tetramerisation domain containing 1 0.01017 2.673429
Bt.16916.1.
S1_at
KLF11 Kruppel-like factor 11 0.010186 2.110118
Bt.11259.1.
S1_at
IFI27 putative ISG12(a) protein 0.010909 3.109152
Bt.17081.2.
S1_at
LMO2 LIM domain only 2 (rhombotin-like 1) 0.011572 -2.37451
Bt.22214.1.
S1_at
CD180 CD180 molecule 0.011606 -2.04421
Bt.7145.1.
S1_at
GZMB /// LOC100125946 granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
/// uncharacterized LOC100125946
0.015009 -3.15552
Bt.20540.1.
S1_at
CD79B CD79b molecule, immunoglobulin-associated beta 0.015089 -3.58646
Bt.20257.2.
S1_at
BCNT2 Bucentaur-2 0.015853 -2.28942
Bt.155.1.S1_at IL8 interleukin 8 0.016 2.249822
(Continued)
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Table 1. (Continued)
Probe ID Gene symbol Gene name P value FC
Bt.24112.1.
A1_at
CXHXorf57 chromosome X open reading frame, human CXorf57 0.016027 -2.76004
Bt.18253.1.
A1_at
KIAA1324L KIAA1324-like ortholog 0.016067 2.359824
Bt.27043.2.
S1_at
FCER1A Fc fragment of IgE, high afﬁnity I, receptor for; alpha polypeptide 0.016226 -2.06287
Bt.13469.1.
S1_at
SDSL serine dehydratase-like 0.016296 -2.5064
Bt.9262.1.
A1_at
SPIB Spi-B transcription factor (Spi-1/PU.1 related) 0.016742 -3.49334
Bt.9974.1.
S1_at
CCL3 chemokine (C-C motif) ligand 3 0.01705 -2.10999
Bt.19014.1.
A1_at
NDUFS3 NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q
reductase)
0.017446 4.152097
Bt.2899.1.
S2_at
FOS FBJ murine osteosarcoma viral oncogene homolog 0.017668 2.486687
Bt.6438.1.
A1_at
TGFB2 transforming growth factor, beta 2 0.019127 3.436742
Bt.3352.1.
S1_at
ASIP agouti signaling protein 0.019681 -2.09284
Bt.9163.2.
S1_at
P2RY10 purinergic receptor P2Y, G-protein coupled, 10 0.019736 -2.0468
Bt.27760.1.
S1_at
BoLA /// BOLA-A major histocompatibility complex, class I, A /// major histocompatibility complex,
class I, A
0.02069 -3.40943
Bt.3805.1.
S1_at
BOLA-N /// JSP.1 ///
LOC100125916
MHC class I antigen /// MHC Class I JSP.1 /// uncharacterized protein
100125016
0.021303 3.897296
Bt.17019.1.
A1_at
FOXP1 Forkhead box P1 0.021388 2.003436
Bt.20640.1.
A1_at
C22H3orf64 chromosome 22 open reading frame, human C3orf64 0.021803 2.039162
Bt.411.1.S1_at NRG1 neuregulin 1 0.021883 2.757968
Bt.11847.1.
A1_at
XIST X (inactive)-speciﬁc transcript 0.023013 -21.2975
Bt.24923.1.
S1_at
SEL1L3 sel-1 suppressor of lin-12-like 3 (C. elegans) 0.023619 -3.25125
Bt.13367.1.
A1_at
XIST X (inactive)-speciﬁc transcript 0.024218 -34.6725
Bt.29820.1.
S1_s_at
BOLA MHC class I heavy chain 0.024899 -6.08329
Bt.23911.1.
A1_at
XIST X (inactive)-speciﬁc transcript 0.025193 -29.733
Bt.22139.1.
S1_at
COBLL1 COBL-like 1 0.026423 -2.76573
Bt.22854.1.
S1_at
CA2 carbonic anhydrase II 0.026826 -2.33612
Bt.13330.1.
S1_at
PDK4 pyruvate dehydrogenase kinase, isozyme 4 0.02815 2.399512
Bt.16070.2.
S1_at
LOC786352 apolipoprotein L, 1-like 0.028855 -2.31442
Bt.17473.2.
S1_at
RPE ribulose-5-phosphate-3-epimerase 0.030357 2.209343
Bt.16966.1.
S1_at
CXCL10 chemokine (C-X-C motif) ligand 10 0.030459 -3.06647
(Continued)
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heat maps representing the differentially expressed probe sets in preclinical and clinical groups
are shown in Fig 1. The complete probe set lists with the relative p values and fold changes can
be found in S1 and S2 Tables.
A gene enrichment analysis was performed to identify the most enriched GO terms in the
clinical and preclinical groups (Fig 2). DEGs specific of the clinical group were clustered in
functional categories related to cytokine-cytokine receptor interaction, regulation of leukocyte
activation, inflammatory response, autoimmune thyroid disease, chemokine activity, B cell
Table 1. (Continued)
Probe ID Gene symbol Gene name P value FC
Bt.23172.1.
S1_at
BAX BCL2-associated X protein 0.030653 -2.28799
Bt.4609.1.
S1_at
LOC100847474 uncharacterized LOC100847474 0.031831 -2.619
Bt.20687.1.
A1_at
C5H12orf35 chromosome 5 open reading frame, human C12orf35 0.032384 2.091363
Bt.3651.2.
A1_at
C15H11orf96 chromosome 15 open reading frame, human C11orf96 0.035164 2.092887
Bt.5408.1.
A1_at
UCHL1 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 0.035211 2.097092
Bt.7015.1.
S1_at
EED embryonic ectoderm development 0.036537 -2.08921
Bt.14010.1.
S1_at
PTGR1 prostaglandin reductase 1 0.03669 -2.19439
Bt.2899.1.
S1_at
FOS FBJ murine osteosarcoma viral oncogene homolog 0.03784 2.465631
Bt.1075.1.
A1_at
ZNF24 zinc ﬁnger protein 24 0.038258 2.707935
Bt.20494.1.
S1_at
RYBP RING1 and YY1 binding protein 0.038552 2.157803
Bt.27261.2.
S1_at
LOC100847574 multidrug resistance-associated protein 4-like 0.040322 3.296289
Bt.23094.1.
A1_at
AKR1C4 /// LOC506594 aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha
hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) ///
prostaglandin F synthase 1-like
0.041102 -2.13672
Bt.20540.3.
A1_at
CD79B CD79b molecule, immunoglobulin-associated beta 0.04229 -2.06338
Bt.24372.1.
S1_at
ZRSR2Y zinc ﬁnger (CCCH type), RNA-binding motif and serine/arginine rich 2 0.042712 3.786694
Bt.7122.1.
S1_at
HELZ helicase with zinc ﬁnger 0.043553 2.564275
Bt.213.1.S1_at CD163L1 CD163 molecule-like 1 0.047294 2.499982
Bt.20216.2.
S1_at
RPIA ribose 5-phosphate isomerase A 0.048256 -2.06759
Bt.27759.2.
S1_at
IDO1 indoleamine 2,3-dioxygenase 1 0.048525 -3.72942
Bt.29815.1.
S1_x_at
BOLA MHC class I heavy chain 0.048538 -3.12234
Bt.15705.1.
S2_at
DSTN destrin (actin depolymerizing factor) 0.048589 2.055416
Bt.16933.2.
A1_at
LOC100298891 aTP-binding cassette, sub-family C (CFTR/MRP), member 4-like 0.049066 2.747912
aFC = fold change.
doi:10.1371/journal.pone.0153425.t001
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Table 2. Functional classification of differentially expressed genes in blood of infected cattle versus control groupa.
Pathway Probe name Gene symbol Gene name P value Fold Enrichment
Autoimmune thyroid
disease
BT.21975.1.
S1_AT
PRF1 perforin 1 (pore forming protein) 1.01E-04 19.14728682
BT.29815.1.
S1_X_AT
BOLA MHC class I heavy chain
BT.29820.1.
S1_S_AT
BOLA MHC class I heavy chain
BT.3805.1.
S1_AT
BOLA-N /// JSP.1 ///
LOC100125916
MHC class I antigen /// MHC Class I
JSP.1 /// uncharacterized protein
100125016
BT.49.1.
S1_AT
CD40LG CD40 ligand
BT.7145.1.
S1_AT
GZMB ///
LOC100125946
granzyme B (granzyme 2, cytotoxic T-
lymphocyte-associated serine esterase
1) /// uncharacterized LOC100125946
Extracellular region BT.155.1.
S1_AT
IL8 interleukin 8 2.22E-04 3.036995516
BT.16070.2.
S1_AT
LOC786352 apolipoprotein L, 1-like
BT.16966.1.
S1_AT
CXCL10 chemokine (C-X-C motif) ligand 10
BT.20330.1.
S1_AT
PRSS23 protease, serine, 23
BT.20640.1.
A1_AT
C22H3orf64 chromosome 22 open reading frame,
human C3orf64
BT.2129.1.
S1_AT
LOC100850064 versican core protein-like
BT.213.1.
S1_AT
CD163L1 CD163 molecule-like 1
BT.29009.1.
A1_AT
RYR3 ryanodine receptor 3
BT.49.1.
S1_AT
CD40LG CD40 ligand
BT.6438.1.
A1_AT
TGFB2 transforming growth factor, beta 2
BT.8804.1.
S1_AT
NELL2 NEL-like 2 (chicken)
BT.9504.1.
A1_AT
CCL4 chemokine (C-C motif) ligand 4
BT.9974.1.
S1_AT
CCL3 chemokine (C-C motif) ligand 3
BT.3352.1.
S1_AT
ASIP agouti signaling protein
Immune response BT.155.1.
S1_AT
IL8 interleukin 8 4.91E-04 5.451442755
BT.16966.1.
S1_AT
CXCL10 chemokine (C-X-C motif) ligand 10
BT.27760.1.
S1_AT
BoLA /// BOLA-A major histocompatibility complex, class
I, A /// major histocompatibility complex,
class I, A
BT.29815.1.
S1_X_AT
BOLA MHC class I heavy chain
BT.29820.1.
S1_S_AT
BOLA MHC class I heavy chain
(Continued)
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Table 2. (Continued)
Pathway Probe name Gene symbol Gene name P value Fold Enrichment
BT.3805.1.
S1_AT
BOLA-N /// JSP.1 ///
LOC100125916
MHC class I antigen /// MHC Class I
JSP.1 /// uncharacterized protein
100125016
BT.49.1.
S1_AT
CD40LG CD40 ligand
BT.9504.1.
A1_AT
CCL4 chemokine (C-C motif) ligand 4
BT.9974.1.
S1_AT
CCL3 chemokine (C-C motif) ligand 3
Chemokine activity BT.155.1.
S1_AT
IL8 interleukin 8 5.42E-04 24.18039216
BT.16966.1.
S1_AT
CXCL10 chemokine (C-X-C motif) ligand 10
BT.9504.1.
A1_AT
CCL4 chemokine (C-C motif) ligand 4
BT.9974.1.
S1_AT
CCL3 chemokine (C-C motif) ligand 3
Locomotory behavior BT.155.1.
S1_AT
IL8 interleukin 8 0.001387806 9.982954545
BT.16966.1.
S1_AT
CXCL10 chemokine (C-X-C motif) ligand 10
BT.5408.1.
A1_AT
UCHL1 ubiquitin carboxyl-terminal esterase L1
(ubiquitin thiolesterase)
BT.9504.1.
A1_AT
CCL4 chemokine (C-C motif) ligand 4
BT.9974.1.
S1_AT
CCL3 chemokine (C-C motif) ligand 3
Inﬂammatory
response
BT.155.1.
S1_AT
IL8 interleukin 8 0.001604508 9.598994755
BT.16966.1.
S1_AT
CXCL10 chemokine (C-X-C motif) ligand 10
BT.49.1.
S1_AT
UCHL1 ubiquitin carboxyl-terminal esterase L1
(ubiquitin thiolesterase)
BT.9504.1.
A1_AT
CCL4 chemokine (C-C motif) ligand 4
BT.9974.1.
S1_AT
CCL3 chemokine (C-C motif) ligand 3
Antigen processing
and presentation via
MHC class I
BT.27760.1.
S1_AT
BoLA /// BOLA-A major histocompatibility complex, class
I, A /// major histocompatibility complex,
class I, A
0.002359977 39.93181818
BT.29820.1.
S1_S_AT
BOLA MHC class I heavy chain
BT.3805.1.
S1_AT
BOLA-N /// JSP.1 ///
LOC100125916
MHC class I antigen /// MHC Class I
JSP.1 /// uncharacterized protein
100125016
BT.29815.1.
S1_X_AT
BOLA MHC class I heavy chain
B cell proliferation BT.23172.1.
S1_AT
BAX BCL2-associated X protein 0.0337752778987117 57.0454545454545
BT.49.1.
S1_AT
CD40LG CD40 ligand
Cell adhesion
molecules (CAMs)
BT.2129.1.
S1_AT
LOC100850064 versican core protein-like 0.038771205 5.105943152
(Continued)
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proliferation and differentiation, regulation of apoptosis, kinase inhibitor activity, and mem-
brane raft (Fig 2B). The preclinical stage was characterized by enrichment in gene clusters
related to chemokine signaling pathway, extracellular region, secreted protein, immune
response, pyridoxal phosphate binding, transcription, myeloid-associated differentiation
marker, B cell proliferation, extracellular matrix, RNA metabolic process, MHC class I, Lami-
nin G and response to wounding (Fig 2A).
When comparing the differentially regulated probe sets identified in the preclinical and clin-
ical groups, it was found that 35 differentially expressed probe sets (corresponding to 32
DEGs) were common between the two stages of disease (Fig 3), leaving 172 DEGs specific to
clinical and 78 genes specific to preclinical animals. Remarkably, all of the 32 common DEGs
displayed a very similar pattern of expression in the clinical and preclinical groups, as shown in
Fig 3B. These genes are listed in bold in S1 and S2 Tables.
To further dissect gene expression alterations during the progression of the disease, we per-
formed a statistical analysis to identify specific changes between the clinical and preclinical
stages (CvsP). Indeed, we found 235 DEGs, which were significantly enriched in pathways
related to immune response (regulation of B cell proliferation, leucocyte activation, ISG15-pro-
tein conjugation and chemokine signaling were among the most significant). The list of the
most relevant enriched probe sets can be found in S3 Table.
We used a Venn diagram to compare the DEGs found in PvsCtrl, CvsCtrl and CvsP analy-
ses that were previously performed and then we examined the expression levels of common
DEGs (Fig 4). Venn diagram revealed the presence of one DEG in common between PvsCtrl,
CvsCtrl and CvsP comparisons, while 22 genes were differentially expressed in PvsCtrl and
CvsP but not in CvsCtrl comparisons (Fig 4A). We found that these 22 DEGs had an opposite
fold change sign in PvsCtrl and CvsP, thus indicating an oscillatory pattern of expression (see
Fig 4B, 4C and Table 3). In particular, 9 out of 22 DEGs were up-regulated in the preclinical
phase and then went back roughly to the expression level of the controls in the clinical stage
(Fig 4B). The remaining 13 out of 22 DEGs were down-regulated in the preclinical phase and
then went back almost to control levels in the clinical phase (Fig 4C). The only gene in com-
mon between the three comparisons, namely Sel-1 Suppressor Of Lin-12-Like 3 (SEL1L3), was
Table 2. (Continued)
Pathway Probe name Gene symbol Gene name P value Fold Enrichment
BT.29820.1.
S1_S_AT
BOLA MHC class I heavy chain
BT.3805.1.
S1_AT
BOLA-N /// JSP.1 ///
LOC100125916
MHC class I antigen /// MHC Class I
JSP.1 /// uncharacterized protein
100125016
BT.49.1.
S1_AT
CD40LG CD40 ligand
BT.29815.1.
S1_X_AT
BOLA MHC class I heavy chain
Regulation of
secretion
BT.27043.2.
S1_AT
FCER1A Fc fragment of IgE, high afﬁnity I,
receptor for; alpha polypeptide
0.048207557 8.319128788
BT.49.1.
S1_AT
CD40LG CD40 ligand
BT.29009.1.
A1_AT
RYR3 ryanodine receptor 3
a The gene enrichment analysis was performed using DAVID bioinformatics tool 6.7 (NIAID/NIH, USA). Only genes with a known GO and belonging to the
most relevant functional categories are represented in the list.
doi:10.1371/journal.pone.0153425.t002
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Fig 1. Heat maps representing the DEGs found in clinical and preclinical cattle with atypical BSE. Two heat maps were generated using the
heatmap.2 function from the gplots library in R statistical environment. DEGs were hierarchically clustered with complete linkage using the Euclidean metric.
The heat maps represent the most significant DEGs (p value.0.05 and fold change 2) in clinical (A) and preclinical (B) animals compared to the control
group. Animals are reported in the x-axis while the differentially expressed probes are in the y-axis.
doi:10.1371/journal.pone.0153425.g001
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progressively down-regulated during the preclinical and the clinical phase of the infection, as
shown in Fig 4D.
Validation of Microarray Results by RT-qPCR
To confirm the microarray results, RT-qPCR analysis was performed using the SYBR1 green
assay. A normalization factor based on three reference genes (glyceraldehyde-3-phosphate
dehydrogenase, GAPDH; ribosomal protein L12, RPL12; actin, beta, ACTB) was used for the
analysis. The stability of the selected reference genes was determined by calculating their geN-
ormM value (M) and the coefficient of variation (CV) on the normalized relative quantities
(S2 Appendix file) [50]. 9 DEGs related to different functional categories were chosen for the
validation: GNLY (granulysin), CD40L (CD40 ligand), PDK4 (pyruvate dehydrogenase lipoa-
mide kinase isozyme 4), IDO1 (indoleamine 2, 3-dioxygenase 1), HBA2 (hemoglobin, alpha 2),
XIST (X-inactive specific transcript), GNB4 (guanine nucleotide binding protein beta polypep-
tide 4), BOLA (MHC class I heavy chain), and SEL1L3 (Table 4).
These genes were selected on the basis of their fold changes, p values and relevance in the
literature. Moreover, because we performed several statistical analyses of the microarray
data, we chose genes that appeared as differentially expressed with the highest frequency in
different resulting datasets. Despite microarray p value for HBA2 was not significant, this
gene was selected for the RT-qPCR validation since a previous work published by our group
highlighted its involvement in prion pathogenesis [51]. The RT-qPCR analysis confirmed
the microarray results for six out of nine genes selected (XIST, CD40L, GNLY, PDK4, HBA2
and SEL1L3), which are represented in Table 5 and Fig 5: CD40L, XIST, SEL1L3 and GNLY
downregulation was confirmed in both preclinical and clinical groups, while HBA2 was
Fig 2. Gene enrichment analysis of DEGs specific of the clinical and preclinical stage of the disease.
The most relevant GO terms (y axis) associated to clinical (A) and preclinical (B) phase are listed according
to decreasing statistical significance from top to bottom. The threshold for statistical significance is marked by
the green lines. The enrichment analysis was performed using DAVID bioinformatics tool 6.7 (NIAID/NIH,
USA).
doi:10.1371/journal.pone.0153425.g002
Whole Blood Gene Expression Profiling in BSE-Infected Cattle
PLOS ONE | DOI:10.1371/journal.pone.0153425 April 13, 2016 14 / 27
significantly down-regulated only in preclinical animals. Significant PDK4 upregulation was
found in the clinical stage, but not in the preclinical one. These results were in line with the
microarray data (Table 5).
Discussion
Whole blood is the most suitable tissue for a prospective rapid diagnostic test since it mini-
mizes sample handling artifacts and reduces sample variability due to fractionation. The pres-
ent study revealed a substantial gene expression alteration in whole blood from atypical BSE-
infected cattle, which could be investigated in future experiments and, if confirmed, could be
exploited as a signature for the disease. One of the major caveats in using peripheral blood is
that its cellular components may change dramatically during infections or inflammation.
The animals used in the present study did not show any apparent side pathology, they were
monitored daily by the husbandry staff and their blood was examined for serum aspartate ami-
notransferase (AST), creatine kinase (CK) and manganese [23]. Nonetheless, possible interfer-
ence due to hidden pathologies or to inter-individual variations in hematocrit and white blood
Fig 3. Identification of common DEGs in blood of preclinical and clinical atypical BSE-infected cattle. (A) Venn diagram showing the number of
differentially expressed probe sets in blood of clinical and preclinical cattle. The intersection in grey represents 35 differentially expressed probe sets
corresponding to 32 differentially expressed genes (DEGs) that are in common between the two stages of the disease. (B) Expression pattern of the common
32 DEGs. The histograms represent the fold change relative to the control group. PvsCtrl = preclinical versus control, CvsCtrl = clinical versus control.
doi:10.1371/journal.pone.0153425.g003
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Fig 4. DEGs in common between CvsP, PvsCtrl and CvsCtrl comparisons. (A) Venn diagram revealed the presence of 22 DEGs in common between
CvsP and PvsCtrl comparisons. One DEG (SEL1L3, Sel-1 Suppressor Of Lin-12-Like 3) was common in the three comparisons. (B-C) The normalized
expression values of the 22 common DEGs for CvsP and PvsCtrl comparisons are represented by the histograms. As indicated by the schematic figures on
the right, these 22 DEGs showed an oscillatory pattern of expression: (B) 9/22 were upregulated in PvsCtrl and then downregulated in CvsP comparisons,
while (C) 13/22 were downregulated in PvsCtrl and upregulated in CvsP comparison, respectively. (D) SEL1L3, the only gene found in common among the
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cell count may affect interpretation of expression data and should be considered as an impor-
tant variable in future studies. In light of this, the present results should be read as a first explo-
ration of whole blood transcriptomics during a prion infection. To our knowledge, this is the
first microarray study of whole blood from BSE-infected cattle. Indeed, in a study published
by Panelli et al. [36], fractionated white blood cells were analyzed to detect gene expression
changes in L-type infected animals. Very few DEGs are common between the two studies.
However, this discrepancy may be explained by different infection methods, microarray plat-
forms, statistical analysis stringency and p value cut-off. Also, the white cells used in the study
of Panelli et al. were isolated from 1 year post-infection animals, while in our study we used
whole blood from preclinical and clinical infected cattle (around 6 months and 22–26 post-
infection respectively).
In the present study, 4 statistical comparisons were performed: infected (preclinical and
clinical) versus control (IvsCtrl), preclinical versus control (PvsCtrl), clinical versus control
(CvsCtrl) and clinical versus preclinical (CvsP) comparisons. Since our goal was to find a com-
mon pattern among all the atypical BSE-infected cattle, we defined them as a single group of
infected (H-type and L-type) animals. Indeed, as published by Konold and colleagues [23],
these animals shared a very similar phenotype in terms of behavioral and clinical signs.
Also, another study by Priemer and colleagues indicated a large similarity at level of PrPSc
three comparisons (CvsP, CvsCtrl and PvsCtrl), showed a progressive downregulation during the preclinical and the clinical phase of the infection.
P = preclinical, C = clinical and Ctrl = control, vs = versus. DEGs = differentially expressed genes.
doi:10.1371/journal.pone.0153425.g004
Table 3. List of DEGs characterized by an up-down/down-up pattern of expression.a
Probe Name Gene Symbol Gene Name Fold Change in PvsCtrl Fold Change in CvsP
Bt.611.1.S2_at CXCL2 chemokine (C-X-C motif) ligand 2 20.96797 -35.4276
Bt.5021.1.S1_at FBN1 ﬁbrillin 1 5.660874 -4.47422
Bt.18013.1.A1_at RERE arginine-glutamic acid dipeptide (RE) repeats 3.399468 -2.66838
Bt.18234.1.S1_at IGSF6 immunoglobulin superfamily, member 6 -3.28943 2.811553
Bt.15334.2.A1_at STAT3 Signal transducer and activator of transcription 3 -3.23829 2.678539
Bt.20833.3.A1_at NHLRC2 NHL repeat containing 2 2.825469 -2.43499
Bt.27161.1.A1_at C16H1orf114 chromosome 16 open reading frame, human C1orf114 2.782753 -2.03538
Bt.17789.1.A1_at ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 -2.77122 5.521504
Bt.21221.1.S1_at LST1 leukocyte speciﬁc transcript 1 -2.55548 2.531317
Bt.3780.1.S1_at C10H5orf13 chromosome 10 open reading frame, human C5orf13 2.480665 -2.2476
Bt.9841.1.S1_at MIR21 microRNA mir-21 -2.45176 3.249144
Bt.18474.2.A1_at SHOC2 soc-2 suppressor of clear homolog (C. elegans) -2.4061 3.30272
Bt.21868.2.S1_at IGSF6 immunoglobulin superfamily, member 6 -2.34146 2.567908
Bt.27421.1.S1_at ARHGEF2 Rho/Rac guanine nucleotide exchange factor (GEF) 2 -2.26254 2.6399
Bt.16088.1.A1_at MYO5C myosin VC 2.260998 -2.64645
Bt.1711.1.A1_at LOC615263 uncharacterized LOC615263 -2.20341 2.511818
Bt.22390.1.S1_at HPS3 Hermansky-Pudlak syndrome 3 2.146785 -2.13082
Bt.1847.1.S1_at LOC789748 Sialic acid-binding Ig-like lectin 14-like -2.12509 2.458681
Bt.2334.1.S1_at CD68 CD68 molecule -2.11618 2.156622
Bt.26430.1.S1_at ZNF184 zinc ﬁnger protein 184 2.099151 -2.31926
Bt.1736.1.A1_at SOCS1 suppressor of cytokine signaling 1 -2.06053 2.221149
Bt.5878.2.S1_at SDS serine dehydratase -2.02673 2.367767
a For each gene the fold changes found in PvsCtrl (preclinical versus control) and CvsP (clinical versus preclinical) comparisons are reported.
doi:10.1371/journal.pone.0153425.t003
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anatomical distribution for the atypical strains, with only slight differences in the overall inten-
sities between H- and L-type [27]. Nonetheless, even if H- and L-type BSE are reported to
share many similarities, they constitute two distinct BSE variants which are characterized by a
different electrophoretic mobility of PrPSc unglycosylated moiety after proteinase K (PK)
Table 4. Genes analyzed by RT-qPCRa.
Gene Primer sequence Amplicon length (bp) Accession number
ACTB* F: GGA CTT CGA GCA GGA GAT GG 148 NM_173979.3
R: TTC CAT GCC CAG GAA GGA AG
GAPDH* F: AGG TCG GAG TGA ACG GAT TC 85 NM_001034034.2
R: ATG GCG ACG ATG TCC ACT TT
RPL12* F: AGG GTC TGA GGA TTA CAG TGA AA 83 NM_205797.1
R: GAT CAG GGC AGA AGC AGA AGG
CD40L F: ACA ACC TCT GTT CTC CAG TG 82 NM_174624.2
R: GTC GTT TCC CGT TTT CGA GG
XIST F: GTG GCA AGG ACC AGA ATG GA 112 NR_001464.2
R: TCC GAC CCC AGT ATT AGC CA
GNLY F: AGC CCG ATG AGA ATA CCG TT 120 NM_001075143.1
R: CGA TGT CCT CAG CGA TGG TA
PDK4 F: TGG TGT TCC CCT GAG AGT CA 109 NM_001101883.1
R: GTA ACC AAA ACC AGC CAG CG
HBA2 F: ACA AGG GCA ATG TCA AGG CC 124 NM_001077422.3
R: TCG AAG TGG GGG AAG TAG GT
GNB4 F: AGA TCG TGC AGG TGT TCT TG 96 NM_001099033.1
R: CTG TCC CAA GAC CCT GTT G
IDO1 F: ATT GGT GGA GTC CCT GCA GAC 150 NM_001101866.2
R: CTG CAG GGT AGC ATT GCC TT
BOLA F: CTC GTA GTA GCT GTG GTG GC 96 NM_001038518.1
R: ACT GTC ACT GCT TGC AGC C
SEL1L3 F: TGA AGG AGT GGTTTC GCC TG 79 NM_001206556.2
R: TTC AAA TCC TGC CCA GTG CT
a Primers (F, forward; R,reverse) used for gene ampliﬁcation, amplicon size, and GenBank1 accession numbers for the bovine cDNA sequences used for
primer design. All primers were designed according to the genome sequence of Bos taurus.
doi:10.1371/journal.pone.0153425.t004
Table 5. Differential expression of selected genes quantified by microarray and RT-qPCR analysis a.
Gene name Gene symbol Microarray fold change RT-qPCR ratio/FC
preclinical clinical preclinical clinical
Granulysin GNLY -6.318 -3.698 0.322/-3.106 0.433/-2.309
X-inactive speciﬁc transcript XIST -33.240 -22.612 0.003/-333.333 0.004/-250.000
Pyruvate dehydrogenase kinase 4 PDK4 1.752 (ns) 5.793 0.665/ -1.503 (ns) 2.536
CD40 ligand CD40L -2.786 -3.761 0.667/-1.499 0.408/-2.450
Haemoglobin, alpha 2 HBA2 -3.866 (ns) -2.259 (ns) 0.269/-3.717 0.816/-1.225 (ns)
Suppressor Of Lin-12-Like Protein 3 SEL1L3 -2.16 -5.17 0.504/-1.984 0.213/-4.695
a For an easier interpretation, the differential expression of the downregulated genes measured by RT-qPCR is reported both as original ratio and as fold
change calculated as -1/ratio. Ns = not signiﬁcant
doi:10.1371/journal.pone.0153425.t005
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digestion [16, 18]. Statistical comparison between the 4 H-type and the 4 L-type infected ani-
mals was carried out in preliminary analyses (see S4 Table), but only a limited number of
DEGs was found. Among them, only 15 had a p value lower than 0.01 and only 16 showed a
fold change higher than 3, indicating that, at least in terms of number of DEGs, these two
groups did not display large differences. For these reasons, we decided to focus our attention
on finding a common gene pattern among all the atypical BSE-infected cattle and therefore we
pooled the two groups. Due to the high inter-animal variability, which is expected for outbreed
animals, further studies in larger animal cohorts would be required to investigate in detail the
strain-specific gene expression changes occurring during the progression of the disease. Still,
the HvsL analysis can be used as a sort of internal control in this study.
Another aspect to be taken into account when reading the present results is that additional
negative control cattle, aged from 12 to 37 months and derived from a different herd compared
to the Konold’s study groups [23], were introduced in the analyses. The addition of these con-
trols was useful to balance the samples from infected animals and allowed a preliminary explo-
ration of the differentially expressed transcripts. However, age-related and environmental
variability may have affected in some degree the data and need to be considered for their cor-
rect interpretation. Despite some limitations, since several statistical analyses were performed
(including the CvsP analysis, in which all the animals derived from the same herd) a cross com-
parison of all them, as we did with the Venn Diagram, may be very useful in order to define a
set of genes which could be a good starting point for further validation experiments in the
future. In the first statistical analysis we performed (IvsC), we found that among 101 DEGs, 93
had known functions and were involved in several biological processes and molecular path-
ways, such as autoimmune thyroiditis, chemokine and cytokine activity, regulation of the
secretion pathway, the immune system and antigen presentation[52]. Previous studies on CNS
tissues from BSE-infected animals also showed the involvement of many of these pathways in
prion pathogenesis [4, 35, 52]. This similarity between brain and blood may not be surprising,
since it has been shown in the literature that blood transcriptome analyses identify genes that
Fig 5. Validation of microarray data by RT-qPCR.Differential expression of selected genes in blood from preclinical (A) and clinical (B) atypical BSE-
infected cattle. Ganulysin (GNLY), X-inactive specific transcript (XIST), pyruvate dehydrogenase kinase 4 (PDK4), CD40 ligand (CD40L), haemoglobin,
alpha 2 (HBA2) and Sel-1 Suppressor Of Lin-12-Like 3 protein (SEL1L3). Gene expression (ratio) values are represented as relative to RNA levels in control
animals. Ns = not significant; *P value 0.05.
doi:10.1371/journal.pone.0153425.g005
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are relevant to the pathological processes occurring in the CNS [53]. Indeed, measuring dis-
ease-related gene expression in peripheral blood may be a useful proxy measure for gene
expression in the CNS [53, 54].
To characterize the gene expression profile in the preclinical and clinical stages, we per-
formed the PvsCtrl and the CvsCtrl statistical comparisons. We found that 113 probe sets were
differentially regulated in the preclinical stage of the disease, while 207 probe sets had an
altered expression in the clinical phase. Importantly, the present results indicated that, at least
in blood, a consistent gene expression alteration is present from the early stages of the disease.
This finding is in agreement with microarray analysis carried out by Tang et al., which revealed
the highest degree of differential gene regulation in brains of cBSE-infected cattle at 21 months
post infection, which is prior to the detection of infectivity [4]. Also, Tortosa and colleagues
found a significant number of DEGs at early stages of the disease in the CNS from cBSE-
infected transgenic mice [52].
Venn diagram analysis revealed that 32 DEGs were in common between the clinical and
preclinical groups and, remarkably, they had a very similar pattern of expression in both stages
of the disease. Since these genes are altered in both phases, it would be very interesting to con-
firm their differential expression in future experiments with additional negative controls, and
eventually in blood from human patients.
Based on GO enrichment analysis, we found that immunity and inflammation processes
were strongly involved during the progression of the disease stages. Interestingly, we found
that antigen processing and presentation via MHC (major histocompatibility complex) mole-
cules and the autoimmune thyroiditis pathway were significantly altered in atypical BSE-chal-
lenged animals. The majority of MHC class I molecule coding-genes were down-regulated in
infected cattle (three out of four probes) and, also, MHC class II molecule coding transcripts
were found to be down-regulated during the progression of the clinical signs (four out of four
probes were down-regulated in the CvsP comparison). The involvement of MHC transcripts in
prion pathogenesis is supported by another microarray study published by Khaniya and col-
leagues in 2009 [55]. In line with the trend found by the microarray analysis, the RT-qPCR val-
idation experiments indicated a downregulation for MHC class I heavy chain (BOLA), even
though the results failed to reach the statistical significance (data not shown).
Regarding the autoimmune thyroiditis pathway, it is well known in the literature that
Hashimoto’s encephalitis, together with the associated thyroiditis, is a differential diagnosis for
CJD, since the two pathologies share a very similar clinical symptomatology [56]. As hypothe-
sized previously by Prusiner and colleagues, the clinical and neuropathological similarities
between CJD and Hashimoto’s thyroiditis raise the possibility that protein misprocessing may
underlie both neurodegenerative and autoimmune diseases [57].
Finally, a fourth statistical analysis was performed to identify any specific changes between
the clinical and the preclinical stages of disease (CvsP). Indeed, we found that the last phases of
the disease are accompanied by the overactivation of several genes involved in the immune
defense response. In particular, the shift from the preclinical towards the clinical stage was
characterized by the upregulation of genes involved in B cell proliferation and the ISG15 (IFN-
induced 15-kDa protein) conjugation system. ISG15 is a ubiquitin-like molecule that is tightly
regulated by specific innate immunity signaling pathways [58]. Interestingly, it has been shown
in the literature that this protein is over-activated in the spinal cord of amyotrophic lateral scle-
rosis mice models [59] and it has been indicated as a general marker for both acute and chronic
neuronal injuries [60].
To further analyze the data, we compared the list of DEGs found in PvsCtrl, CvsP and CvsCtrl
and found 22 genes with an oscillatory pattern of expression, being differentially expressed in
the preclinical stage and then going back roughly to the control level in the clinical stage.
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Interestingly, some of the oscillatory DEGs are involved in regulation of transcription, thus sug-
gesting that the gene expression during atypical BSE infection is tightly regulated. Venn diagram
analysis revealed that one gene, SEL1L3, was down-regulated in all the comparisons (PvsCtrl,
CvsCtrl, CvsP). SEL1L3 codes for a transmembrane protein whose function is unknown. Inter-
estingly, an important paralog of SEL1L3, SEL1L, is involved in the retrotranslocation of mis-
folded proteins from the lumen of the endoplasmic reticulum to the cytosol, where they are
degraded by the proteasome in an ubiquitin-dependent manner [61]. Therefore, we could
hypothesize that its down-regulation in prion infected animals would lead to a reduced degrada-
tion of PrPSc, thus supporting the progression of the disease. We validated this gene by RT-
qPCR, confirming its downregulation in both the preclinical and clinical stages of the disease.
Further investigation on the function of SEL1L3L would be of great interest since this gene may
play an important role in prion disease and maybe other neurodegenerative illnesses.
Besides SEL1L3, five other genes were validated by RT-qPCR; here we will briefly discuss
how these genes may be involved in prion pathogenesis and in host response to prion infection.
GNLY and CD40L were found to be down-regulated in both preclinical and clinical stages.
GNLY is a powerful antimicrobial protein contained within the granules of cytotoxic T lym-
phocyte and natural killer cells. This gene was found to be downregulated also in a microarray
study performed on the medulla oblongata from sheep with preclinical natural scrapie [62].
Thus, it may be a good candidate as an early biomarker for atypical BSE but also for other
prion diseases.
CD40–CD40L interactions mediate a broad variety of immune and inflammatory responses
and have been implicated in the pathogenesis of Alzheimer’s disease (AD) [63, 64]. Although
the importance of CD40L in prion disease progression has not yet been clarified (66–68), its
downregulation in blood during both preclinical and clinical stages of atypical BSE-infection
suggests that prion infection has an impact on the host immune system response and that
immune tolerance may be an active process induced by prions.
Two other downregulated genes were validated by RT-qPCR, namelyHBA2 and XIST. Con-
cerning HBA2, we found a downregulation in preclinical atypical BSE-infected cattle. Haemo-
globins are iron-containing proteins that transport oxygen in the blood of most vertebrates.
Beside blood, HBA andHBB are also expressed in mesencephalic dopaminergic neurons and
glial cells [65] and are down regulated in AD, PD and other neurodegenerative diseases [66].
Haemoglobin genes expression alteration during preclinical scrapie was also found in the
spleen and CNS of infected animals [67, 68], as well as in the brains of nonhuman primates
infected with BSE [51]. These findings suggest an involvement of these genes in the host
response to general neurodegenerative processes. Besides changes in transcript levels, it has
been found that both HbA and HbB protein distribution is altered in mitochondrial fractions
from PD degenerating brain [69]. Moreover, HbA is also expressed in endothelial cells, where
it regulates the nitric oxide signaling [70]. Even though a clear mechanism linking these mole-
cules to neurodegeneration has not yet been described, taken together these findings strongly
suggest a central role for haemoglobin in neurodegenerative processes.
A marked downregulation in XIST expression was found in our infected animals. XIST is a
gene located on X chromosomes which codes for a long non-coding RNA (LncRNA) involved
in X-chromosome dosage control [71, 72]. LncRNAs are emerging as useful biomarkers for
neurodegenerative diseases such as AD [73] and other disease processes [74], and they can be
easily detected in blood and urine from patients. In addition, we cannot exclude the possibility
that the alteration in XIST expression may have some role in gender-dependent response to
prion infection [75].
RT-qPCR experiments confirmed the upregulation of PDK4 in clinically affected animals.
PDK4 encodes for a mitochondrial protein involved in glucose metabolism through the
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inhibition of pyruvate dehydrogenase complex, which leads to a reduction in pyruvate conver-
sion to acetyl-CoA [76]. In the literature, a key role has been suggested for acetyl-CoA fueling
for the survival of cholinergic neurons in the course of neurodegenerative diseases [77]. PDK4
overactivation can lead to a switch from glucose catabolism to fatty acid utilization [78], thus
increasing the production of ketone bodies. Notably, it has been shown in the literature that
these molecules are able to cross the blood brain barrier. We could speculate that in prion
infection (or at least in atypical BSE infection) the concentration of ketone bodies would rise in
blood, as a consequence of PDK4 upregulation, and act in the brain as neuroprotective mole-
cules [79, 80]. This would be an attempt by the organism to prevent the neurodegeneration
induced by prions.
Conclusions
In conclusion, the present study has led to the identification of several gene expression changes
in whole blood from clinical and preclinical atypical BSE cattle, which upon further investiga-
tion and validation in blood from human patients, might represent a molecular fingerprint to
characterize this disease. By comparing our results with other studies on various animal prion
diseases, we observed that some of the most significantly altered DEGs we found in blood were
found differentially expressed also in brain tissue from BSE-infected cattle; this observation
indicates that whole blood transcriptome analyses may serve as a proxy measure for the
changes occurring in the CNS of infected animals. Furthermore, our study underlines the
importance of utilizing whole blood, without any additional manipulation, as a source tissue as
it is an easily accessible body fluid. In addition, the transcription regulation activated in atypical
BSE infections is similar to some extent to the one observed in the literature for cBSE, even
though the clinical characteristics and biochemical properties are very different. Thus, this
gene expression profile may be investigated in other BSE infections to identify a common
molecular fingerprint.
Overall, our study confirmed the differential expression of 6 genes (XIST, CD40L, GNLY,
PDK4,HBA2 and SEL1L3), which may play several roles in atypical BSE pathogenesis and, pos-
sibly, in other prion infections. Indeed, they are involved in multiple pathways such as immune
response, inflammation, and glucose catabolism. Even though further studies are required to
investigate the specific involvement of all the identified genes in prion diseases, our data indi-
cate an important role for immune system regulation in the prion pathogenesis of atypical BSE
and maybe in BSE as well as in other prion diseases in general.
Supporting Information
S1 Appendix. Post hybridization quality assessment. (A) Normalized unscaled standard
error (NUSE), (B) relative log expression (RLE) and (C) raw signal intensity plots are used
to check for technical problems and to spot outlier samples after GCRMA normalization.
Box plots centered higher than normal (typically above 1.1 in the NUSE plot) and/or having a
larger spread in the RLE plots represent arrays with quality problems. One outlier was easily
identified by post hybridization quality assessment (black arrow in panel A and B, control sam-
ple cS5).
(TIF)
S2 Appendix. Reference gene expression stability. Stability of the selected reference genes
was determined by calculating their geNormM value (M) (A) and the coefficient of variation
(CV) (B) on the normalized relative quantities (CNRQ). The dashed green lines in panel A
and B indicate the maximum acceptable threshold for M and CV values, respectively. These
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thresholds have been empirically determined by previous experiments performed by Helle-
mans et al. (see ref. 42).
(TIF)
S1 Table. Differentially expressed genes found in preclinical animals versus controls
(PvsCtrl) by the microarray analysis. FC = fold change. Common DEGs between preclinical
and clinical animals are highlighted in bold.
(XLSX)
S2 Table. Differentially expressed genes found in clinical animals versus controls (CvsCtrl)
by the microarray analysis. FC = fold change. Common DEGs between preclinical and clinical
animals are highlighted in bold.
(XLSX)
S3 Table. Functional classification of differentially expressed genes found in blood of clini-
cal versus preclinical animals. The gene enrichment analysis was performed using DAVID
bioinformatics tool 6.7 (NIAID/NIH, USA). Only genes with a known GO are represented in
the list. The DEGs which fell in more than one category for simplicity are presented under a
single functional heading. FC and P values refer to the microarray analysis.
(XLSX)
S4 Table. List of DEGs found in HvsL statistical comparison. FC = fold change.
(XLSX)
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